Basic info
Industry
biotechnology research
Sectors
Biotechnology
cancer
Therapeutics
Biopharma
Health Care
Immunotherapeutics
Date founded
2016
Funding rounds raised
Total raised
$101M
from 17 investors over 17 rounds
X
Xilio Therapeutics, Inc. raised $95M on February 24, 2021
Investors: RiverVest Venture Partners, RA Capital Management, L.P., SV Life Sciences, Takeda UK Limited and Atlas Venture
X
Xilio Therapeutics, Inc. raised $101M on March 2, 2020
Investors: RiverVest Venture Partners, SV Life Sciences, Takeda UK Limited, M Ventures, Solasta Ventures, Atlas Venture, F-Prime Capital Partners and Bay City Capital
X
Xilio Therapeutics, Inc. raised $30M on September 27, 2018
Investors: Atlas Venture, F-Prime Capital Partners and SV Life Sciences
X
Xilio Therapeutics, Inc. raised $7.5M on October 12, 2016
Investors: F-Prime Capital Partners